{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:46:03Z","timestamp":1778809563725,"version":"3.51.4"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194081","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T13:35:45Z","timestamp":1520602545000},"page":"e0194081","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Socioeconomic inequality in medication persistence in primary and secondary prevention of coronary heart disease \u2013 A population-wide electronic cohort study"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4341-5620","authenticated-orcid":true,"given":"William","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arron","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Farewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-5281","authenticated-orcid":true,"given":"Frank","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"e000737","DOI":"10.1136\/bmjopen-2011-000737","article-title":"Trends in social inequalities for premature coronary heart disease mortality in Great Britain, 1994\u20132008: a time trend ecological study","volume":"2","author":"D McCartney","year":"2012","journal-title":"BMJ Open"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/01.CIR.0000118498.35499.B2","article-title":"Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000","volume":"109","author":"B Unal","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"e1001237","DOI":"10.1371\/journal.pmed.1001237","article-title":"Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000\u20132007: a population modelling study","volume":"9","author":"M Bajekal","year":"2012","journal-title":"PLoS medicine"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1742-1241.2007.01630.x","article-title":"The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review","volume":"62","author":"JA Cramer","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"PM Ho","year":"2008","journal-title":"Am Heart J"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect","volume":"166","author":"MA Brookhart","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"8","key":"ref7","doi-asserted-by":"crossref","first-page":"e1000320","DOI":"10.1371\/journal.pmed.1000320","article-title":"Will cardiovascular disease prevention widen health inequalities?","volume":"7","author":"S Capewell","year":"2010","journal-title":"PLoS Med"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.numecd.2010.09.010","article-title":"Statin use after first myocardial infarction in UK men and women from 1997 to 2006: Who started and who continued treatment?","volume":"22","author":"IM Carey","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10557-007-6040-4","article-title":"Predictors of adherence to statins for primary prevention","volume":"21","author":"DM Mann","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1517\/14656560903376186","article-title":"Non-adherence to statin therapy: a major challenge for preventive cardiology","volume":"10","author":"TR Bates","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/14740330802396984","article-title":"Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality","volume":"7","author":"EN Liberopoulos","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.clinthera.2006.09.021","article-title":"Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization","volume":"28","author":"PA Caetano","year":"2006","journal-title":"Clin Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"JA Cramer","year":"2008","journal-title":"Value Health"},{"issue":"7696","key":"ref14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0140-6736(71)92410-X","article-title":"The inverse care law","volume":"297","author":"JT Hart","year":"1971","journal-title":"The Lancet"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-7-96","article-title":"Practice size, caseload, deprivation and quality of care of patients with coronary heart disease, hypertension and stroke in primary care: national cross sectional study","volume":"7","author":"S Saxena","year":"2007","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-9276-4-3","article-title":"Exploring the equity of GP practice prescribing rates for selected coronary heart disease drugs: a multiple regression analysis with proxies of healthcare need","volume":"4","author":"PR Ward","year":"2005","journal-title":"Int J Equity Health"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"e0172618","DOI":"10.1371\/journal.pone.0172618","article-title":"Equity in healthcare for coronary heart disease, Wales (UK) 2004\u20132010: A population-based electronic cohort study","volume":"12","author":"W King","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1472-6963-9-157","article-title":"The SAIL Databank: building a national architecture for e-health research and evaluation","volume":"9","author":"DV Ford","year":"2009","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"ref19","article-title":"The SAIL databank: linking multiple health and social care datasets","volume":"9","author":"RA Lyons","year":"2009","journal-title":"BMC Med Inform DecisionMaking"},{"key":"ref20","unstructured":"Welsh index of multiple deprivation 2008: Technical report; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wales.gov.uk\/topics\/statistics\/publications\/publication-archive\/wimd2008tech\/?lang=en;2009\" xlink:type=\"simple\">http:\/\/wales.gov.uk\/topics\/statistics\/publications\/publication-archive\/wimd2008tech\/?lang=en;2009<\/ext-link>"},{"key":"ref21","unstructured":"Department of Health. National Service Framework for Coronary Heart Disease. 2000 (Department of Health, London)."},{"key":"ref22","unstructured":"National Service Framework for Coronary Heart Disease. 2001. (National Assembly for Wales, Cardiff)"},{"key":"ref23","unstructured":"National Institute for Clinical Excellence (2001) Prophylaxis for patients who have experienced a myocardial infarction. (CGA)"},{"key":"ref24","unstructured":"National Institute for Clinical Excellence (2002) Management of type 2 diabetes\u2013management of blood pressure and blood lipids (CGH)"},{"key":"ref25","unstructured":"National Institute for Health and Clinical Excellence (2004) Hypertension: management of hypertension in adults in primary care (CG18)"},{"key":"ref26","unstructured":"National Institute for Health and Clinical Excellence (2006) Hypertension: management of hypertension in adults in primary care (CG34)"},{"key":"ref27","unstructured":"National Institute for Health and Clinical Excellence (2008) Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (CG67)"},{"key":"ref28","unstructured":"Bentley T, Price C, Brown P; Structural and lexical features of successive versions on the Read codes; in The Proceedings of the 1996 Annual Conference of The Primary Health Care Specialist Group; 1996."},{"key":"ref29","unstructured":"All Wales Medicines Strategy Group. All Wales Review and Guidance for Prescribing Intervals. 2013. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.awmsg.org\/docs\/awmsg\/medman\/All%20Wales%20Review%20and%20Guidance%20for%20Prescribing%20Intervals.pdf\" xlink:type=\"simple\">http:\/\/www.awmsg.org\/docs\/awmsg\/medman\/All%20Wales%20Review%20and%20Guidance%20for%20Prescribing%20Intervals.pdf<\/ext-link>. Accessed December 2016"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"d2410","DOI":"10.1136\/bmj.d2410","article-title":"Some PCTs recommend GPs limit prescriptions to 28 days","volume":"342","author":"A O\u2019Dowd","year":"2011","journal-title":"BMJ"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"ME Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"RB D'Agostino Sr","year":"2008","journal-title":"Circulation"},{"key":"ref33","unstructured":"Therneau T. coxme: Mixed effects Cox models. R package version. 2012;2(3)."},{"issue":"Suppl","key":"ref34","first-page":"S17","article-title":"Safer medicines management in primary care","volume":"52","author":"AJ Avery","year":"2002","journal-title":"Br J Gen Pract"},{"issue":"412","key":"ref35","first-page":"649","article-title":"The scale of repeat prescribing","volume":"46","author":"CM Harris","year":"1996","journal-title":"Br J Gen Pract"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMsa055505","article-title":"Pay-for-performance programs in family practices in the United Kingdom","volume":"355","author":"T Doran","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2003.12.041","article-title":"Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study","volume":"117","author":"KA Eagle","year":"2004","journal-title":"Am J Med"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ahj.2005.02.038","article-title":"Long-term adherence with cardiovascular drug regimens","volume":"151","author":"SP Kulkarni","year":"2006","journal-title":"Am Heart J"},{"issue":"19","key":"ref39","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/eurheartj\/ehr340","article-title":"Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction\u2014a hospital registry-primary care linked cohort (MINAP\u2013GPRD)","volume":"32","author":"R Boggon","year":"2011","journal-title":"Eur Heart J"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jech.58.2.89","article-title":"Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England","volume":"58","author":"PR Ward","year":"2004","journal-title":"J Epidemiol Community Health"},{"issue":"7249","key":"ref41","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/bmj.320.7249.1583","article-title":"Use of statins in general practices, 1996\u20138: cross sectional study","volume":"320","author":"C Packham","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/pubmed\/21.1.60","article-title":"Statin prescribing in Nottingham general practices: a cross-sectional study","volume":"21","author":"C Packham","year":"1999","journal-title":"J Public Health (Oxf)"},{"key":"ref43","first-page":"R11","article-title":"Equity of health care: a ward-based analysis of primary care prescribing","volume":"261","author":"NS Bradshaw","year":"1998","journal-title":"Pharm J"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-9276-6-2","article-title":"How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England","volume":"6","author":"P R Ward","year":"2007","journal-title":"Int J Equity Health"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/pubmed\/fdl068","article-title":"Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner \u2018Quality and Outcomes Framework\u2019","volume":"29","author":"M Ashworth","year":"2007","journal-title":"J Public Health (Oxf)"},{"issue":"5","key":"ref46","doi-asserted-by":"crossref","first-page":"A","DOI":"10.1016\/S0016-5085(09)60311-5","article-title":"408 Increased aspirin use and upper gastrointestinal bleeding rates in socially deprived patients","volume":"136","author":"Y Vinogradova","year":"2009","journal-title":"Gastroenterology"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/pubmed\/fdn048","article-title":"Explanations for variations in clopidogrel prescribing in England","volume":"30","author":"D Petty","year":"2008","journal-title":"J Public Health (Oxf)"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1464-5491.2008.02544.x","article-title":"Introduction of a new incentive and target-based contract for family physicians in the UK: good for older patients with diabetes but less good for women?","volume":"25","author":"M P McGovern","year":"2008","journal-title":"Diabetic Medicine"},{"key":"ref49","article-title":"The UK National Health Service","author":"N Hawkins","year":"2013","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"11","key":"ref50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/jech.2005.044628","article-title":"Deprivation and quality of primary care services: evidence for persistence of the inverse care law from the UK Quality and Outcomes framework","volume":"60","author":"G McLean","year":"2006","journal-title":"J Epidemiol Community Health"},{"issue":"9640","key":"ref51","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0140-6736(08)61123-X","article-title":"Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes framework","volume":"372","author":"T Doran","year":"2008","journal-title":"The Lancet"},{"issue":"22","key":"ref52","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJMsa1107913","article-title":"Full coverage for preventive medications after myocardial infarction","volume":"365","author":"NK Choudhry","year":"2011","journal-title":"N Eng J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T11:38:01Z","timestamp":1540294681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194081"}},"subtitle":[],"editor":[{"given":"Katriina","family":"Aalto-Setala","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194081","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}